Top

Clinical Oral Investigations

Published in:

01-12-2017 | Original Article

Low-serum culture with novel medium promotes maxillary/mandibular bone marrow stromal cell proliferation and osteogenic differentiation ability

Authors: Fumio Suehiro, Masakazu Ishii, Izumi Asahina, Hiroshi Murata, Masahiro Nishimura

Published in: Clinical Oral Investigations | Issue 9/2017

Abstract

Objectives

The purpose of this study was to evaluate the effect of low-serum STK2 medium on the isolation and osteogenic differentiation of human maxillary/mandibular bone marrow stromal cells (MBMSCs).

Materials and methods

Human MBMSCs were obtained from patients undergoing dental implant treatment. These cells were cultured in serum-free medium or STK2 medium containing 1 % fetal bovine serum (low-serum) or α-MEM containing 10 % fetal bovine serum (control). Proliferation on the culture surface, cell surface antigen expression, and mRNA levels of neural crest and osteogenic markers were examined. Alkaline phosphatase assay and Alizarin red staining were used to assess osteogenic differentiation potential. Immunoblotting analysis was performed to detect ERK phosphorylation.

Results

Low-serum and control MBMSCs were positive for CD73, CD90, and CD105 and negative for CD14, CD34, CD45, CD271, and HLA-DR. CD140a was absent in low-serum cells but present in control cells. Low-serum MBMSCs proliferated more than control MBMSCs. After induction of osteogenic differentiation, alkaline phosphatase activity and osteocalcin mRNA levels were higher in low-serum MBMSCs than in control cells, and Alizarin red staining was stronger in low-serum MBMSCs than in control cells. Low-serum culture promoted ERK phosphorylation.

Conclusions

MBMSCs precultured in low-serum medium exhibited a greater cumulative cell number and a higher osteogenic differentiation capacity than those cultured in control medium.

Clinical relevance

These findings indicate that low-serum STK2 culture might be useful to promote MBMSC proliferation and osteogenic differentiation. This method requires less autologous blood collection for cell expansion than conventional methods, thus reducing the burden on patients.

Caplan AI, Bruder SP (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7(6):259–264CrossRefPubMed

Deans RJ, Moseley AB (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28(8):875–884CrossRefPubMed

Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. Journal of embryology and experimental morphology 16(3):381–390PubMed

Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147CrossRefPubMed

Matsubara T, Suardita K, Ishii M, Sugiyama M, Igarashi A, Oda R, Nishimura M, Saito M, Nakagawa K, Yamanaka K, Miyazaki K, Shimizu M, Bhawal UK, Tsuji K, Nakamura K, Kato Y (2005) Alveolar bone marrow as a cell source for regenerative medicine: differences between alveolar and iliac bone marrow stromal cells. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20(3):399–409. doi:10.1359/JBMR.041117 CrossRef

Igarashi A, Segoshi K, Sakai Y, Pan H, Kanawa M, Higashi Y, Sugiyama M, Nakamura K, Kurihara H, Yamaguchi S, Tsuji K, Kawamoto T, Kato Y (2007) Selection of common markers for bone marrow stromal cells from various bones using real-time RT-PCR: effects of passage number and donor age. Tissue Eng 13(10):2405–2417. doi:10.1089/ten.2006.0340 CrossRefPubMed

Kaigler D, Pagni G, Park CH, Braun TM, Holman LA, Yi E, Tarle SA, Bartel RL, Giannobile WV (2013) Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplant 22(5):767–777. doi:10.3727/096368912X652968 CrossRefPubMedPubMedCentral

Yamada Y, Nakamura S, Ito K, Umemura E, Hara K, Nagasaka T, Abe A, Baba S, Furuichi Y, Izumi Y, Klein OD, Wakabayashi T (2013) Injectable bone tissue engineering using expanded mesenchymal stem cells. Stem Cells 31(3):572–580. doi:10.1002/stem.1300 CrossRefPubMedPubMedCentral

Egusa H, Sonoyama W, Nishimura M, Atsuta I, Akiyama K (2012) Stem cells in dentistry—part I: stem cell sources. Journal of prosthodontic research 56(3):151–165. doi:10.1016/j.jpor.2012.06.001 CrossRefPubMed

10.

Zhao H, Chai Y (2015) Stem cells in teeth and craniofacial bones. J Dent Res 94(11):1495–1501. doi:10.1177/0022034515603972 CrossRefPubMedPubMedCentral

11.

Shinagawa K, Mitsuhara T, Okazaki T, Takeda M, Yamaguchi S, Magaki T, Okura Y, Uwatoko H, Kawahara Y, Yuge L, Kurisu K (2015) The characteristics of human cranial bone marrow mesenchymal stem cells. Neurosci Lett 606:161–166. doi:10.1016/j.neulet.2015.08.056 CrossRefPubMed

12.

Egusa H, Sonoyama W, Nishimura M, Atsuta I, Akiyama K (2012) Stem cells in dentistry—part II: clinical applications. Journal of prosthodontic research 56(4):229–248. doi:10.1016/j.jpor.2012.10.001 CrossRefPubMed

13.

Mason S, Tarle SA, Osibin W, Kinfu Y, Kaigler D (2014) Standardization and safety of alveolar bone-derived stem cell isolation. J Dent Res 93(1):55–61. doi:10.1177/0022034513510530 CrossRefPubMedPubMedCentral

14.

Chai Y, Jiang X, Ito Y, Bringas P Jr, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM (2000) Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127(8):1671–1679PubMed

15.

Mishina Y, Snider TN (2014) Neural crest cell signaling pathways critical to cranial bone development and pathology. Exp Cell Res 325(2):138–147. doi:10.1016/j.yexcr.2014.01.019 CrossRefPubMedPubMedCentral

16.

Koole R, Bosker H, van der Dussen FN (1989) Late secondary autogenous bone grafting in cleft patients comparing mandibular (ectomesenchymal) and iliac crest (mesenchymal) grafts. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 17(Suppl 1):28–30CrossRef

17.

Nishimura M, Takase K, Suehiro F, Murata H (2012) Candidates cell sources to regenerate alveolar bone from oral tissue. International journal of dentistry 2012:857192. doi:10.1155/2012/857192 CrossRefPubMedPubMedCentral

18.

Vacanti JP, Langer R, Upton J, Marler JJ (1998) Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev 33(1–2):165–182PubMed

19.

Mannello F, Tonti GA (2007) Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25(7):1603–1609. doi:10.1634/stemcells.2007-0127 CrossRefPubMed

20.

Nuttall PA, Luther PD, Stott EJ (1977) Viral contamination of bovine foetal serum and cell cultures. Nature 266(5605):835–837CrossRefPubMed

21.

Mizuno D, Agata H, Furue H, Kimura A, Narita Y, Watanabe N, Ishii Y, Ueda M, Tojo A, Kagami H (2010) Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum. Growth Factors 28(1):34–43. doi:10.3109/08977190903326362 CrossRefPubMed

22.

Aldahmash A, Haack-Sorensen M, Al-Nbaheen M, Harkness L, Abdallah BM, Kassem M (2011) Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo. Stem Cell Rev 7(4):860–868. doi:10.1007/s12015-011-9274-2 CrossRefPubMed

23.

Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR (2007) Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213(1):18–26. doi:10.1002/jcp.21081 CrossRefPubMed

24.

Tsutsumi S, Shimazu A, Miyazaki K, Pan H, Koike C, Yoshida E, Takagishi K, Kato Y (2001) Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288(2):413–419. doi:10.1006/bbrc.2001.5777 CrossRefPubMed

25.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317. doi:10.1080/14653240600855905 CrossRefPubMed

26.

Aghaloo TL, Chaichanasakul T, Bezouglaia O, Kang B, Franco R, Dry SM, Atti E, Tetradis S (2010) Osteogenic potential of mandibular vs. long-bone marrow stromal cells. J Dent Res 89(11):1293–1298. doi:10.1177/0022034510378427 CrossRefPubMedPubMedCentral

27.

Akintoye SO, Lam T, Shi S, Brahim J, Collins MT, Robey PG (2006) Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone 38(6):758–768. doi:10.1016/j.bone.2005.10.027 CrossRefPubMed

28.

De Souza Faloni AP, Schoenmaker T, Azari A, Katchburian E, Cerri PS, De Vries TJ, Everts V (2011) Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int 88(1):63–74CrossRefPubMed

29.

Ishikawa I, Sawada R, Kato Y, Tsuji K, Shao J, Yamada T, Kato R, Tsuchiya T (2009) Effectivity of the novel serum-free medium STK2 for proliferating human mesenchymal stem cells. Yakugaku Zasshi 129(3):381–384CrossRefPubMed

30.

Mittag F, Falkenberg EM, Janczyk A, Gotze M, Felka T, Aicher WK, Kluba T (2012) Laminin-5 and type I collagen promote adhesion and osteogenic differentiation of animal serum-free expanded human mesenchymal stromal cells. Orthop Rev 4(4):e36. doi:10.4081/or.2012.e36 CrossRef

31.

Schleicher I, Parker A, Leavesley D, Crawford R, Upton Z, Xiao Y (2005) Surface modification by complexes of vitronectin and growth factors for serum-free culture of human osteoblasts. Tissue Eng 11(11–12):1688–1698. doi:10.1089/ten.2005.11.1688 CrossRefPubMed

32.

Guillot PV, De Bari C, Dell'Accio F, Kurata H, Polak J, Fisk NM (2008) Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation; research in biological diversity 76(9):946–957. doi:10.1111/j.1432-0436.2008.00279.x CrossRefPubMed

33.

Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, Gotting C (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52(2):227–234. doi:10.1373/clinchem.2005.059253 CrossRefPubMed

34.

Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112(3):357–366. doi:10.1172/JCI17202 CrossRefPubMedPubMedCentral

35.

Houlihan DD, Mabuchi Y, Morikawa S, Niibe K, Araki D, Suzuki S, Okano H, Matsuzaki Y (2012) Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-alpha. Nat Protoc 7(12):2103–2111. doi:10.1038/nprot.2012.125 CrossRefPubMed

36.

Mabuchi Y, Morikawa S, Harada S, Niibe K, Suzuki S, Renault-Mihara F, Houlihan DD, Akazawa C, Okano H, Matsuzaki Y (2013) LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem cell reports 1(2):152–165. doi:10.1016/j.stemcr.2013.06.001 CrossRefPubMedPubMedCentral

37.

Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ (2014) Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15(2):154–168. doi:10.1016/j.stem.2014.06.008 CrossRefPubMedPubMedCentral

38.

Maeda K, Enomoto A, Hara A, Asai N, Kobayashi T, Horinouchi A, Maruyama S, Ishikawa Y, Nishiyama T, Kiyoi H, Kato T, Ando K, Weng L, Mii S, Asai M, Mizutani Y, Watanabe O, Hirooka Y, Goto H, Takahashi M (2016) Identification of Meflin as a potential marker for mesenchymal stromal cells. Scientific reports 6:22288. doi:10.1038/srep22288 CrossRefPubMedPubMedCentral

39.

Harkness L, Zaher W, Ditzel N, Isa A, Kassem M (2016) CD146/MCAM defines functionality of human bone marrow stromal stem cell populations. Stem cell research & therapy 7:4. doi:10.1186/s13287-015-0266-z CrossRef

Title: Low-serum culture with novel medium promotes maxillary/mandibular bone marrow stromal cell proliferation and osteogenic differentiation ability
Authors: Fumio Suehiro
Masakazu Ishii
Izumi Asahina
Hiroshi Murata
Masahiro Nishimura
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 9/2017
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-017-2073-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low-serum culture with novel medium promotes maxillary/mandibular bone marrow stromal cell proliferation and osteogenic differentiation ability

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 9/2017

Temperature evolution of preheated irrigant injected into a root canal ex vivo

Presence of root canal treatment has no influence on periodontal bone loss

Root canal morphology and variations in mandibular second molar teeth of an Indian population: an in vivo cone-beam computed tomography analysis

Impact of caries and dental fluorosis on oral health-related quality of life: a cross-sectional study in schoolchildren receiving water naturally fluoridated at above-optimal levels

Intravenous lidocaine for effective pain relief after bimaxillary surgery

Asymmetric bone remodeling in mandibular and maxillary tori